Spectrum of adult Parvovirus B19 infection according to the underlying predisposing condition and proposals for clinical practice

British Journal of Haematology

Volumn 170, Issue 2, 2015, Pages 192-199

  Wolfromm, Alice ^a   Rodriguez, Christophe ^a,b   Michel, Marc ^a   Habibi, Anoosha ^a   Audard, Vincent ^a,b   Benayoun, Emmanuel ^a   Rogier, Olivier ^a   Challine, Dominique ^a   Chosidow, Olivier ^a,c,d   Lelièvre, Jean Daniel ^a,b   Chevalier, Xavier ^a   Le Bras, Fabien ^a   Pautas, Cécile ^a   Imbert, Michèle ^a   Pawlotsky, Jean Michel ^a,b   Wagner Ballon, Orianne ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b INSERM U955   (France)

^c French Satellite of the Cochrane Skin Group   (France)

^d INSERM   (France)

Author keywords

Anaemia; Human parvovirus B19; Pure red cell aplasia; Underlying predisposing condition

Indexed keywords

ADOLESCENT; ADULT; AGED; BIOPSY; BONE MARROW; COMPLICATION; DISEASE MANAGEMENT; DISEASE PREDISPOSITION; ERYTHEMA INFECTIOSUM; FEMALE; GENETICS; HEREDITARY HEMOLYTIC ANEMIA; HUMAN; HUMAN PARVOVIRUS B19; IMMUNOCOMPROMISED PATIENT; MALE; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, HEMOLYTIC, CONGENITAL; BIOPSY; BONE MARROW; DISEASE MANAGEMENT; DISEASE SUSCEPTIBILITY; ERYTHEMA INFECTIOSUM; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; PARVOVIRUS B19, HUMAN; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84934442808     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13421     Document Type: Article

References (33)

1. Anderson, M.J., Higgins, P.G., Davis, L.R., Willman, J.S., Jones, S.E., Kidd, I.M., Pattison, J.R. & Tyrrell, D.A. (1985) Experimental parvoviral infection in humans. The Journal of Infectious Diseases, 152, 257-265.
2. Barlow, G.D. & McKendrick, M.W. (2000) Parvovirus B19 causing leucopenia and neutropenia in a healthy adult. The Journal of Infection, 40, 192-195.
3. Beersma, M.F.C., Claas, E.C.J., Sopaheluakan, T. & Kroes, A.C.M. (2005) Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology, 34, 71-75.
4. Brown, K.E., Anderson, S.M. & Young, N.S. (1993) Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science (New York, N.Y.), 262, 114-117.
5. Brown, K.E., Hibbs, J.R., Gallinella, G., Anderson, S.M., Lehman, E.D., McCarthy, P. & Young, N.S. (1994) Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). The New England Journal of Medicine, 330, 1192-1196.
6. Bültmann, B.D., Klingel, K., Sotlar, K., Bock, C.-T. & Kandolf, R. (2003) Parvovirus B19: a pathogen responsible for more than hematologic disorders. Virchows Archiv: An International Journal of Pathology, 442, 8-17.
7. Chen, S. & Howard, O. (2004) Images in clinical medicine. Parvovirus B19 infection. The New England Journal of Medicine, 350, 598.
8. Chen, A.Y., Zhang, E.Y., Guan, W., Cheng, F., Kleiboeker, S., Yankee, T.M. & Qiu, J. (2010) The small 11 kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells. Blood, 115, 1070-1080.
9. Crabol, Y., Terrier, B., Rozenberg, F., Pestre, V., Legendre, C., Hermine, O., Montagnier-Petrissans, C., Guillevin, L. & Mouthon, L. & Groupe d'experts de l'Assistance Publique-Hôpitaux de Paris (2013) Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 56, 968-977.
10. Dessypris, E. & Lipton, J. (2004) Red Cell Aplasia. In Wintrobe's Clinical Hematology. (ed. by John Greer et al.), pp. 1421-1438. Wolters Kluwer, Lippincott Williams & Wilkins Heath, Chichester, West Sussex, UK.
11. Enders, M., Schalasta, G., Baisch, C., Weidner, A., Pukkila, L., Kaikkonen, L., Lankinen, H., Hedman, L., Söderlund-Venermo, M. & Hedman, K. (2006) Human parvovirus B19 infection during pregnancy-value of modern molecular and serological diagnostics. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology, 35, 400-406.
12. Guo, Y.-M., Ishii, K., Hirokawa, M., Tagawa, H., Ohyagi, H., Michishita, Y., Ubukawa, K., Yamashita, J., Ohteki, T., Onai, N., Kawakami, K., Xiao, W. & Sawada, K. (2010) CpG-ODN 2006 and human parvovirus B19 genome consensus sequences selectively inhibit growth and development of erythroid progenitor cells. Blood, 115, 4569-4579.
13. Hamon, M.D., Newland, A.C. & Anderson, M.J. (1988) Severe aplastic anaemia after parvovirus infection in the absence of underlying haemolytic anaemia. Journal of Clinical Pathology, 41, 1242.
14. Hoffbrand, A. & Moss, P. (2011) Haemolytic anaemias. In: Essential Haematology, pp. 73-87. Wiley-Blackwell, Philadelphia, PA, USA.
15. Kurtzman, G.J., Cohen, B., Meyers, P., Amunullah, A. & Young, N.S. (1988) Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet, 2, 1159-1162.
16. Mage, V., Lipsker, D., Barbarot, S., Bessis, D., Chosidow, O., Del Giudice, P., Aractingi, S., Avouac, J., Bernier, C., Descamps, V. & Dupin, N. (2014) Different patterns of skin manifestations associated with parvovirus B19 primary infection in adults. Journal of the American Academy of Dermatology, 71, 62-69.
17. Maple, P.A.C., Hedman, L., Dhanilall, P., Kantola, K., Nurmi, V., Söderlund-Venermo, M., Brown, K.E. & Hedman, K. (2014) Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study. Journal of Clinical Microbiology, 52, 947-956.
18. Mishra, B., Malhotra, P., Ratho, R.K., Singh, M.P., Varma, S. & Varma, N. (2005) Human parvovirus B19 in patients with aplastic anemia. American Journal of Hematology, 79, 166-167.
19. Muir, K., Todd, W.T., Watson, W.H. & Fitzsimons, E. (1992) Viral-associated haemophagocytosis with parvovirus-B19-related pancytopenia. Lancet, 339, 1139-1140.
20. Munakata, Y., Saito-Ito, T., Kumura-Ishii, K., Huang, J., Kodera, T., Ishii, T., Hirabayashi, Y., Koyanagi, Y. & Sasaki, T. (2005) Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood, 106, 3449-3456.
21. Osaki, M., Matsubara, K., Iwasaki, T., Kurata, T., Nigami, H., Harigaya, H. & Baba, K. (1999) Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease. Annals of Hematology, 78, 83-86.
22. Potter, C.G., Potter, A.C., Hatton, C.S., Chapel, H.M., Anderson, M.J., Pattison, J.R., Tyrrell, D.A., Higgins, P.G., Willman, J.S. & Parry, H.F. (1987) Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19). The Journal of Clinical Investigation, 79, 1486-1492.
23. Qian, X.H., Zhang, G.C., Jiao, X.Y., Zheng, Y.J., Cao, Y.H., Xu, D.L. & Chen, C.S. (2002) Aplastic anaemia associated with parvovirus B19 infection. Archives of Disease in Childhood, 87, 436-437.
24. Ramage, J.K., Hale, A., Gane, E., Cohen, B., Boyle, M., Mufti, G. & Williams, R. (1994) Parvovirus B19-induced red cell aplasia treated with plasmapheresis and immunoglobulin. Lancet, 343, 667-668.
25. Saarinen, U.M., Chorba, T.L., Tattersall, P., Young, N.S., Anderson, L.J., Palmer, E. & Coccia, P.F. (1986) Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood, 67, 1411-1417.
26. Saunders, P.W., Reid, M.M. & Cohen, B.J. (1986) Human parvovirus induced cytopenias: a report of five cases. British Journal of Haematology, 63, 407-410.
27. Serjeant, B.E., Hambleton, I.R., Kerr, S., Kilty, C.G. & Serjeant, G.R. (2001) Haematological response to parvovirus B19 infection in homozygous sickle-cell disease. Lancet, 358, 1779-1780.
28. Servant-Delmas, A., Lefrère, J.-J., Morinet, F. & Pillet, S. (2010) Advances in human B19 erythrovirus biology. Journal of Virology, 84, 9658-9665.
29. Slavov, S.N., Kashima, S., Pinto, A.C.S. & Covas, D.T. (2011) Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions. FEMS Immunology and Medical Microbiology, 62, 247-262.
30. Smith-Whitley, K., Zhao, H., Hodinka, R.L., Kwiatkowski, J., Cecil, R., Cecil, T., Cnaan, A. & Ohene-Frempong, K. (2004) Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood, 103, 422-427.
31. Weigel-Kelley, K.A., Yoder, M.C. & Srivastava, A. (2003) Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood, 102, 3927-3933.
32. White, D.G., Woolf, A.D., Mortimer, P.P., Cohen, B.J., Blake, D.R. & Bacon, P.A. (1985) Human parvovirus arthropathy. Lancet, 1, 419-421.
33. Young, N.S. & Brown, K.E. (2004) Parvovirus B19. The New England Journal of Medicine, 350, 586-597.